The Senate passed a short-term continuing resolution (CR) this week, preventing a government shutdown and extending federal funding through March 11. The chamber also confirmed Robert Califf to be the next Food and Drug Administration (FDA) Commissioner.
Senate Passes Short-Term CR. On February 17, the Senate approved (65-27) a continuing resolution (CR) to provide short-term funding to federal programs through March 11. The CR passed the House of Representatives on February 7, and now heads to President Biden for his signature. The Senate also voted on three amendments, which all failed: (1) Amendment #4929 offered by Senator Lee which aimed to defund all federal COVID-19 vaccine mandates (vote 46-47); (2) Amendment #4927 offered by Senator Cruz on stopping federal funding to schools and child care centers that require COVID-19 vaccines (44-49); and (3) Amendment #4930 offered by Senator Braun requiring a balanced federal budget (47-45), which would have required 60 affirmative votes to pass.
The stopgap funding bill will avoid a government shutdown when the current continuing resolution expires today, February 18. Appropriators will now have three more weeks to reach a bipartisan agreement on fiscal year 2022 spending bills. Republicans and Democrats are close to reaching a bipartisan agreement and remain optimistic that they will produce a comprehensive funding measure by the deadline.
Conversations around additional COVID-19 relief are ongoing. This week, the Department of Health and Human Services (HHS) gave Congress a $30 billion funding request focused mostly on testing and vaccine procurement and development.
This request included:
The Administration request did not include funding for international vaccine distribution or broader potential Administration needs beyond HHS. Nor did it include any additional direct support for healthcare providers despite urgent pleas from hospitals and other healthcare providers for more support for the Provider Relief Fund. Members of Congress from both parties have questioned whether HHS needs additional funding on top of previously allocated dollars, leaving questions as to whether Congress will provide additional COVID funding.
Senate Confirms Robert Califf as FDA Commissioner. After over a year without a Senate-confirmed FDA lead, the Senate narrowly approved Dr. Robert Califf to be the next FDA Commissioner. Dr. Califf previously briefly served as FDA Commissioner at the end of the Obama Administration. However, his ties to the pharmaceutical industry since then brought new scrutiny. Commissioner Califf faces a significant workload in his new role, including working to successfully negotiate and deliver user fee agreements (UFA) to Congress for full consideration and passage. Current UFAs are set to expire on September 30, 2022, at which point the FDA would face significant furloughs and program funding shortages.
Senate Finance Committee Holds Second Hearing on Youth Mental Health. On February 15, the Senate Committee on Finance held a hearing on “Protecting Youth Mental Health: Part II – Identifying and Addressing Barriers to Care”. The hearing discussed the role telehealth can play in rural health and in schools by increasing access to specialty providers, acting to de-stigmatize mental health, fostering formal partnerships with community behavioral health providers and training non-mental health clinicians. There was also discussion concerning the challenges associated with telehealth, such as reimbursement, access to broadband, and state licensure requirements. The conversation also touched on the mental health workforce, specifically around adequate reimbursement in Medicaid.
This hearing follows last week’s committee hearing on February 8 which focused on a U.S. Surgeon General Advisory and call to action regarding the youth mental health crisis. Key members of the Committee are outlining comprehensive mental health legislation for consideration later this year. The House Energy and Commerce Committee also held a hearing on mental health on February 17, entitled “American’s in Need: Responding to the National Mental Health Crisis.”
CMS Reconsiders Direct Contracting Model. Under pressure from progressive Democratic members, the Biden Administration has been weighing changes to the Direct Contracting model. Direct Contracting models, including the Global, Professional and Geographic models, were created during the Trump Administration. The Global and Professional Direct Contracting models build on 10-years of accountable care organization (ACO) policy and represent the next step in the evolution from Pioneer and Next Generation ACO models, at the Centers for Medicare & Medicaid Services Innovation Center. A third option, the Geographic Direct Contracting model, seems to be provoking the most angst among lawmakers given that it would have allowed random attribution of beneficiaries and participation by a broader array of entity types. Notably, the Biden Administration placed the Geographic model on hold and to date, it has not been implemented.
Direct Contracting came under fire during the Senate Finance Committee hearing on February 2, entitled “The Hospital Insurance Trust Fund and the Future of Medicare Financing“, during which Chairwoman Elizabeth Warren (D-MA) called upon the Biden Administration to end the model immediately. However, this week the tenor of the debate seemed to change, as Don Berwick, a former Obama-era CMS Administrator, was quoted in the press saying it would be disruptive if the model were simply stopped cold and over 200 provider organizations urged the Administration to amend the model rather than ending it. An announcement on the future of the model, and any modifications, is expected soon.
Future Uncertain for the Public Health Emergency. The current national public health emergency (PHE) runs through April 16, 2022 and the Biden Administration has indicated it will give a 60-day notice before allowing the PHE to expire. This week, we passed the 60-day mark leaving many stakeholders anticipating a renewal. Calls to end the PHE are growing, particularly from Republicans. Some 70 House Republicans, led by Energy and Commerce Committee Republican lead Cathy McMorris Rodgers (R-WA), sent a letter to President Biden on February 10 calling on the Administration to submit a plan to end the PHE. This week, the Federation of American Hospitals, among others, weighed in with a letter to the Department of Health and Human Services expressing support for another PHE extension. Many health policy flexibilities are tied to the PHE, including telehealth flexibilities, state and federal regulatory modifications, and additional waivers for healthcare providers. Without congressional or agency action to extend or modify these flexibilities, stakeholders have noted that there may be adverse impacts across the health system.
Next week, both the House and Senate will be on recess giving lawmakers a brief week back in their districts before returning to Washington, DC to negotiate the FY 22 appropriations package. Additionally, decisions around funding for an additional COVID-19 relief and the expiration of healthcare policies tied to the PHE will likely garner congressional attention. Preparations are also under way for the State of the Union on March 1, 2022.
For more information, contact Debra Curtis, Madeline Hodge, Rachel Kosh, Kristen O’Brien or Erica Stocker.
To subscribe to the McDermottPlus Check-Up, please CLICK HERE.
